Disclaimer: Procana makes no claims to diagnose, treat or cure the following conditions. The following statements have not been approved by the FDA. Clinical research, case studies and articles below are for research purposes only.


Procana

Cannabinoid Research Studies

Procana is accepting applications to further its own studies in these areas.


Parkinsons Disease (PD)

What is Parkinsons Disease (PD)?

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common occurring in more than a third of people with PD.Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".

Procana Medical Studies [Apply]

Procana is accepting applicants to participate in medical studies of controlled dosage CBD for the treatment of Parkinsons Disease. “CBD” Cannabidiol subset studies will be derived from either Cannabis “Marijuana” or Industrial Hemp. Other medical studies may include ratios of “THC” Tetrahydrocannabinol derived from Cannabis, also known as Marijuana to study the treatment for Parkinsons Disease.

Procana does not warrant, nor does it have approval from the FDA to claim, diagnose or treat any illness or disease with its products containing Hemp, Cannabis or Marijuana with THC or CBD for the treatment of Parkinsons Disease.

To participate in these ongoing studies, please click here.

PubMed

Most of the PubMed material consists of abstracts on preclinical research involving single cannabinoid molecules, test tubes, petri dishes, animal experiments, and in some cases human cell-line studies. Although all mammals have cell receptors that respond pharmacologically to cannabinoid compounds, data from animal experiments and other preclinical research is not always applicable to humans.

This data may include articles, surveys, studies or opinions related to THC and CBD from either Marijuana, Cannabis or Hemp in the use of Parkinsons Disease. This information is for research purposes only, and does not include the use of Procana products.